Get it on Google Play

Radiopharm completes FDA end-of-phase 2 meeting for RAD101

October 5, 2026 8:01 AM EDT Send to a Friend
Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX) announced the completion of an End-of-Phase 2 meeting with the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login